Pharmaceuticals in Developing Countries
The Economist has an interesting article on how pharmaceutical companies are trying to hawk their wares in developing countries (“Quagmire or goldmine?“) Generally, Pharma has stayed away from selling in developing countries due to uncertainties in their level of patent protection. For instance, Brazil has “threatened to invoke compulsory licensing (a legal mechanism that, in…